Sarah Harrell Kester, FNP-C Family Medicine Medicare: Medicare Enrolled Practice Location: 201 W Mcpherson Ave, Nashville, GA 31639 Phone: 229-638-6726 Fax: 229-518-4425 |
Mandy Katrice Lucas, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1221 E. Mcpherson Avenue, Suite A, Nashville, GA 31939 Phone: 229-433-8741 Fax: 229-433-8742 |
Dr. Henry R Richbourg, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 416a E Mcpherson Ave, Nashville, GA 31639 Phone: 229-686-2093 Fax: 229-686-7150 |
Dr. Celestine Stiles, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 418 E. Mcpherson Ave, Nashville, GA 31639 Phone: 229-686-9715 Fax: 229-543-1282 |
Jonathan David Wade, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 110 S Jefferson St, Nashville, GA 31639 Phone: 229-638-6726 Fax: 229-518-4425 |
Richard E Wheeler, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 416 E Mcpherson Ave Ste A, Nashville, GA 31639 Phone: 229-686-2093 |
Dr. Clifton Blayne Thomas, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 201 W Mcpherson Ave, Nashville, GA 31639 Phone: 229-638-6726 |
News Archive
About 1,100 people each year die in the UK from lung cancer related to indoor radon, but current government protection policies focus mainly on the small number of homes with high radon levels and neglect the 95% of radon related deaths caused by lower levels of radon, according to a study published on bmj.com.
New mobile phone software will help epidemiologists and ecologists working in the field to analyse their data remotely and map findings across the world, without having to return to the lab, according to research published in PLoS One today. The authors of the study, from Imperial College London, say the software will also enable members of the public to act as 'citizen scientists' and help collect data for community projects.
GlaxoSmithKline today announced the results of a U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) meeting to discuss the supplemental New Drug Application (sNDA) for AvodartĀ® (dutasteride) for reducing the risk of prostate cancer in men at risk for the disease, defined as those who have had a prior negative biopsy due to clinical concern and have an elevated serum prostate-specific antigen (PSA).
The new discovery could mean that children and adults with growth hormone disorders will not have to have injections as often, reducing the need for daily treatments.
Students with symptoms of sleep disorders are more likely to receive bad grades in classes such as math, reading and writing than peers without symptoms of sleep disorders, according to a research abstract presented at SLEEP 2007, the 21st Annual Meeting of the Associated Professional Sleep Societies (APSS).
› Verified 9 days ago